Evidence map›Paper›PMID 34579200›Full record

ArticleVaccines2021

Risk Factors for Herpes Zoster in Patients with Chronic Kidney Disease: A Case-Control Study.

Zhenxing Li, Qiao Wang, Jiahui Ma, Zhi Li, Dong Huang, Yuzhao Huang, Haocheng Zhou

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Herpes Zoster in Aging Patients: Risk Factors and Prevention Strategies.International journal of general medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis-A Population-Based Cohort Study.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhenxing LiDepartment of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Qiao WangDepartment of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Jiahui MaDepartment of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Zhi LiDepartment of Nephrology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Dong HuangDepartment of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Yuzhao HuangDepartment of Orthopedics, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Haocheng ZhouDepartment of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China.ORCID 0000-0001-6260-2005
Central South University · CN

Funding

National Natural Science Foundation of China 81771101National Natural Science Foundation of China 81901146the Huizhiyucai Project of the Third Xiangya Hospital, Central South University 2020the Key Laboratory of Hunan Province Grants 2018TP1009
6 · The paper itself

Abstract

(1) Background: Chronic kidney disease (CKD) increases the susceptibility to the presence of herpes zoster (HZ). Little is known about the risk factors of HZ in CKD patients; (2) Methods: This is a case-control study. CKD patients diagnosed with HZ between January 2015 and June 2021 in a tertiary hospital were identified. One age- and gender- matched control was paired for each case, matched to the date of initial HZ diagnosis. Conditional multiple logistic regression was used to evaluate the risk factors associated with the presence of HZ; (3) Results: Forty-seven HZ patients and controls were identified. In general, about 73.40% (69 out of 94) patients were classified at IV to V stages of CKD. Immunosuppressive agents (

Indexed as

case-controlchronic kidney diseaseherpes zosterrisk factor

Identifiers

PMID34579200
PMCPMC8473266
OpenAlexW3197000787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.